Literature DB >> 22933512

Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review.

Frederick J de Serres1, Ignacio Blanco.   

Abstract

Genetic epidemiological studies on the prevalence and numbers of individuals with α1-antitrypsin deficiency in each of 97 countries worldwide were used to estimate the numbers in each of the five following phenotypic classes: PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ. These 97 countries were then grouped into 10 major geographic regions to make it possible to compare the numbers in each of these five phenotypic classes in immediately adjacent countries. Such groupings also make it possible to review the spread of the PI*S and PI*Z alleles from one major geographic grouping to another in the world as well as the spread of these two deficiency alleles within a major geographic region. The data in the 10 tables on the numbers in each of the five phenotypic classes in the countries in the same geographic region as well as the prevalence of the PI*S and PI*Z alleles in countries in the same geographic region provide a novel database for the identification of large numbers of individuals in a given phenotypic class. The database also provides useful information for the identification of countries with high numbers of PI*ZZ individuals for augmentation therapy within a given geographic region.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933512     DOI: 10.1177/1753465812457113

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  47 in total

1.  Severe postoperative wound healing disturbance in a patient with alpha-1-antitrypsin deficiency: the impact of augmentation therapy.

Authors:  Marionna Cathomas; Alexandra Schüller; Daniel Candinas; Roman Inglin
Journal:  Int Wound J       Date:  2015-03-26       Impact factor: 3.315

Review 2.  Advances in Alpha-1 Antitrypsin Gene Therapy.

Authors:  Reka Lorincz; David T Curiel
Journal:  Am J Respir Cell Mol Biol       Date:  2020-11       Impact factor: 6.914

3.  Reply: interactions and clarifying group-specific estimates by using stratification.

Authors:  Kevin Molloy; Tomas P Carroll; Craig P Hersh; Jessica A Lasky-Su; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

4.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

5.  IntraIndividual Variability in Serum Alpha-1 Antitrypsin Levels.

Authors:  Annie Haillot; Andrée-Anne Pelland; Yohan Bossé; Tomás P Carroll; François Maltais; Ronald J Dandurand
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

Review 6.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

7.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

Review 8.  Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors:  Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

9.  A Novel Approach to Screening for Alpha-1 Antitrypsin Deficiency: Inpatient Testing at a Teaching Institution.

Authors:  James J Tasch; Ann T McLaughlan; Asad A Nasir
Journal:  Chronic Obstr Pulm Dis       Date:  2018-04-01

10.  Epidemiological correlation between COVID-19 epidemic and prevalence of α-1 antitrypsin deficiency in the world.

Authors:  Hiroshi Yoshikura
Journal:  Glob Health Med       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.